Piedmont Office Realty Trust, Inc. Class A Common Stock (PDM)

Corporate bonds offer yield opportunities and diversification away from equity investments. Investment-grade bonds are safer but lower yield, while high-yield bonds offer higher returns but from riskier firms.

Some picks have performed quite well. Some have been disappointing. Here are the results so far.

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per share on revenue of $301.83 million.

The stock market started the first week of the year down, with the decline in the S&P 500 being driven by a big drop in shares of Apple, as that stock makes up a large part of the index. The same is true for the Nasdaq, of course.

Commercial real estate loans are facing an increase in new delinquencies, primarily driven by offices, which account for 80% of these defaults.

PDM stock results show that Piedmont Office Realty met analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Investors seeking some solace amid possible shifting tides in the market can potentially take cover with high-yield REITs.

PDM stock results show that Piedmont Office Realty met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Inflation unexpectedly surges, shattering hopes for Fed rate cuts & sending stocks down. Core inflation also exceeded expectations. No sector escapes losses, with real estate hit hardest.

Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.

  On Tuesday, 386 stocks made new 52-week lows.

A lot of what happens regarding dividends takes place in public, which often makes it possible to sniff out risks before they become problems.

July 2023's dividends started off the third quarter of 2023 the way June 2023's dividends ended the second quarter. Unimpressively.

Value investors should consider these 3 REITs that have seen their shares fall over this past year but hold future promise.

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

  Tuesday's session saw 286 companies set new 52-week lows.

  On Monday, 147 stocks made new 52-week lows.